Correction to: Monoclonal anti‑CGRP antibodies in post‑menopausal women: a real‑life study

被引：0
|
作者：
Simona Guerzoni
Carlo Baraldi
Daria Brovia
Maria Michela Cainazzo
Flavia Lo Castro
Luca Pani
机构：
[1] AOU Policlinico di Modena,Digital and Predictive Medicine, Pharmacology and Clinical Metabolic Toxicology
[2] University of Modena and Reggio Emilia,Headache Center and Drug Abuse
[3] University of Modena and Reggio Emilia,Laboratory of Clinical Pharmacology and Pharmacogenomics, Department of Specialist Medicines
[4] University of Modena and Reggio Emilia,PhD School in Neurosciences, Department of Biomedical, Metabolic and Neural Sciences
[5] University of Miami,Post
[6] VeraSci,Graduate School in Pharmacology, Department of Biomedical, Metabolic and Neural Sciences
来源：
Acta Neurologica Belgica | 2023年 / 123卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2075 / 2075
相关论文
共 50 条
  • [1] Monoclonal anti-CGRP antibodies in post-menopausal women: a real-life study
    Simona, Guerzoni
    Carlo, Baraldi
    Daria, Brovia
    Michela, Cainazzo Maria
    Flavia, Lo Castro
    Luca, Pani
    ACTA NEUROLOGICA BELGICA, 2023, 123 (03) : 1039 - 1047
  • [2] Monoclonal anti-CGRP antibodies in post-menopausal women: a real-life study
    Simona Guerzoni
    Carlo Baraldi
    Daria Brovia
    Maria Michela Cainazzo
    Flavia Lo Castro
    Luca Pani
    Acta Neurologica Belgica, 2023, 123 : 1039 - 1047
  • [3] Monoclonal anti-CGRP antibodies in post-menopausal women: a real-life study (vol 123, pg 1039, 2023)
    Guerzoni, Simona
    Baraldi, Carlo
    Brovia, Daria
    Cainazzo, Maria Michela
    Lo Castro, Flavia
    Pani, Luca
    ACTA NEUROLOGICA BELGICA, 2023, 123 (05) : 2075 - 2075
  • [4] Evaluation of the risk of hypertension in patients treated with anti-CGRP monoclonal antibodies in a real-life study
    Simona Guerzoni
    Flavia Lo Castro
    Daria Brovia
    Carlo Baraldi
    Luca Pani
    Neurological Sciences, 2024, 45 : 1661 - 1668
  • [5] Evaluation of the risk of hypertension in patients treated with anti-CGRP monoclonal antibodies in a real-life study
    Guerzoni, Simona
    Castro, Flavia Lo
    Brovia, Daria
    Baraldi, Carlo
    Pani, Luca
    NEUROLOGICAL SCIENCES, 2024, 45 (04) : 1661 - 1668
  • [6] Safety and tolerability of anti-CGRP monoclonal antibodies: a real-world study
    Corral-Quereda, C.
    Sanchez-Casado, L.
    Diaz-de-Teran, J.
    Sastre-Real, M.
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 120 - 121
  • [7] Safety and tolerability of anti-CGRP monoclonal antibodies: a real-world study
    Corral-Quereda, C.
    Sanchez-Casado, L.
    Diaz-de-Teran, J.
    Sastre-Real, M.
    CEPHALALGIA, 2021, 41 (1_SUPPL) : 179 - 179
  • [8] European multicenter study on the use of anti-CGRP monoclonal antibodies in real life for migraine prevention: study cohort description
    Caronna, Edoardo
    Jose Gallardo, Victor
    Alpuente, Alicia
    Torres-Ferrus, Marta
    Huerta Villanueva, Mariano
    Munoz, Albert
    Campoy, Sergio
    Cuadrado Godia, Elisa
    Dorado, Laura
    Obach, Victor
    Fabregat, Neus
    Rodriguez Vico, Jaime
    Diaz de Teran, Javier
    Membrilla, Javier
    Pascual, Julio
    Garate, Gabriel
    Gago, Ana
    Guerrero, Angel
    Sanahuja, Jordi
    Sanchez Soblechero, Antonio
    Lozano Ros, Alberto
    Irimia Sieira, Pablo
    Sanchez del Rio, Margarita
    Echeverria Urabayen, Amaya
    Garcia Azorin, David
    Gonzalez Osorio, Yesica
    Gonzalez Quintanilla, Vicente
    Lopez Bravo, Alba
    Fernandez Lazaro, Iris
    Quintas Gutierrez, Sonia
    Gonzalez-Martinez, Alicia
    Flores Pina, Belen
    Manera Zorrilla-Lequerica, Paula
    Jaimes Sanchez, Alex
    Garcia Gomez, Andrea
    Alvarez Escudero, Rocio
    Oterino Duran, Agustin
    Velasco Juanes, Fernando
    Sifontes, Walter
    Rodriguez Montolio, Joana
    Nieves Castellanos, Candela
    Olivier, Marina
    Layos-Romero, Almudena
    Andres Lopez, Alberto
    Sanchez Caballero, Francisco
    Beltran Blasco, Isabel
    Millan Vazquez, Manuel
    Lamas Perez, Raquel
    Viguera Romero, Javier
    Santos-Lasaosa, Sonia
    CEPHALALGIA, 2023, 43 (1supp)
  • [9] Long-term effectiveness of monoclonal anti-CGRP antibodies in patients with migraine in real life
    Perez Prol, C.
    Espinoza Vinces, C.
    Villino Rodriguez, R.
    Atorrasagasti Villar, A.
    Gimeno Rodriguez, M.
    Benitez Martinez, B.
    Beistegui Sarobe, M.
    Sanchez del Rio, M.
    Irimia Sieira, P.
    JOURNAL OF HEADACHE AND PAIN, 2024, 25
  • [10] Workplace disability and anti-CGRP monoclonal antibodies: a study on absenteeism
    Granato, A.
    Bartole, L.
    Garascia, G.
    Manganotti, P.
    JOURNAL OF HEADACHE AND PAIN, 2024, 25
12345